Who owns ORUKA THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Oruka Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Oruka Therapeutics stock

Who bought or sold ORUKA THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Fairmount Funds Management 3.2M $79M 100% Sep 2024
 View chart
VR Adviser 3.1M $76M 100% Sep 2024
 View chart
Commodore Capital 1.4M $34M 100% Sep 2024
 View chart
Perceptive Advisors 1.2M $30M 100% Sep 2024
 View chart
Avidity Partners Management 791k $19M 100% Sep 2024
 View chart
Franklin Resources 721k $20M 100% Sep 2024
 View chart
Paradigm Biocapital Advisors 720k $18M 100% Sep 2024
 View chart
Braidwell 516k $13M 100% Sep 2024
 View chart
Dr. Jeffrey R. Jay, M.D. 515k $13M 100% Sep 2024
 View chart
Point72 Asset Management 482k $12M 100% Sep 2024
 View chart
Frazier Life Sciences Management 477k $12M 100% Sep 2024
 View chart
Redmile Group 412k $10M 100% Sep 2024
 View chart
Woodline Partners 391k $9.6M 100% Sep 2024
 View chart
Affinity Asset Advisors 350k $8.6M 100% Sep 2024
 View chart
Driehaus Capital Management 309k $7.6M 100% Sep 2024
 View chart
T. Rowe Price Associates 280k $6.9M 100% Sep 2024
 View chart
TD Asset Management 95k $2.2M 100% Sep 2024
 View chart
Cowen And Company 58k $1.4M 100% Sep 2024
 View chart
Citigroup 27k $655k 100% Sep 2024
 View chart
Ensign Peak Advisors 25k $613k 100% Sep 2024
 View chart
BlackRock 22k $529k 100% Sep 2024
 View chart
Geode Capital Management 14k $343k 100% Sep 2024
 View chart
Susquehanna International 13k $306k 100% Sep 2024
 View chart
Activest Wealth Management 166.00 $4.1k 100% Sep 2024
 View chart
New England Capital Financial Advisors 41.00 $1.0k 100% Sep 2024
 View chart
Parallel Advisors 20.00 $490.000000 100% Sep 2024
 View chart
Bank of America Corporation 15.00 $367.500000 100% Sep 2024
 View chart